Aktienanalyse zu Huron Consulting Group Inc (HURN)HURNHuron Consulting Group Inc

Huron Consulting Group Inc. is a global professional service. The Company operates in three segments: Healthcare, Education, and Commercial. The Healthcare segment serves acute care providers, including national and regional health systems; academic health systems; community health systems; the federal health system; and public, children’s and critical access hospitals, and non-acute care providers, including physician practices and medical groups, payors, and long-term care or post-acute providers. The Education segment serves public and private colleges and universities, research institutes, not-for-profit organizations and other education-related organizations. The Commercial segment is focused on serving industries and organizations facing significant disruption and regulatory change by helping them adapt to rapidly changing environments and accelerate business transformation. Its products include TriZetto’s Facets, QNXT, and HealthEdge solutions. It operates in the Industrials sector (SERVICES-MANAGEMENT CONSULTING SERVICES industry).

Huron Consulting Group Inc is a good buy right now due to its strong financial performance and positive market sentiment. The current price is $174.86, and the company has a forward P/E ratio of 15.50, which is attractive compared to its peers. Additionally, the recent earnings report showed a 15.7% revenue increase in Q2 2026, with revenues reaching $465.6 million. However, the main risk is the insider selling activity, which has increased by 196.55% over the last month, indicating potential concerns among insiders.

4 analysts cover HURN: 2 rate it Buy, 2 Hold and 0 Sell. The average price target is 211.00.